arrow_back Back to App

Influenza Protection: Faster Vaccines, Better Tests, and Combating Misinformation.

This act aims to strengthen the nation's defense against seasonal and pandemic influenza. It focuses on accelerating vaccine production, improving access to diagnostic tests, and combating false information about vaccinations. This means citizens can expect faster access to protective measures and better healthcare in the event of an influenza threat.
Key points
Faster Vaccines: The goal is to deliver first doses of a new influenza strain vaccine within 12 weeks of its emergence.
Universal Vaccine: Plans are in place to develop a universal influenza vaccine within 10 years, offering broader protection.
Improved Testing and Treatment: Development of rapid home and point-of-care diagnostic tests, plus programs to facilitate access to antiviral medications.
Combating Misinformation: Establishing public-private partnerships to counter false information about vaccines and increase public trust.
Strengthening Stockpiles: Increasing national stockpiles of medications, testing equipment, and vaccine production materials for pandemic preparedness.
Funding: Ensuring sustained funding for influenza-related programs, including research, vaccine production, and pandemic readiness.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_5846
Sponsor: Rep. Larsen, Rick [D-WA-2]
Process start date: 2023-09-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Protecting America from Seasonal and Pandemic Influenza Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_5846.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-09-29.

What are the main provisions?

Key points include:

  • Faster Vaccines: The goal is to deliver first doses of a new influenza strain vaccine within 12 weeks of its emergence.
  • Universal Vaccine: Plans are in place to develop a universal influenza vaccine within 10 years, offering broader protection.
  • Improved Testing and Treatment: Development of rapid home and point-of-care diagnostic tests, plus programs to facilitate access to antiviral medications.
  • Combating Misinformation: Establishing public-private partnerships to counter false information about vaccines and increase public trust.
  • Strengthening Stockpiles: Increasing national stockpiles of medications, testing equipment, and vaccine production materials for pandemic preparedness.
  • Funding: Ensuring sustained funding for influenza-related programs, including research, vaccine production, and pandemic readiness.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Larsen, Rick [D-WA-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health